Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-19

Clinical Trial Update: CCRT Followed by Tegafur, Gimeracil and Oteracil Potassium in Cervical Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates on chemoradiotherapy followed by tegafur-based therapy in cervical cancer (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tegafur, Gimeracil and Oteracil Potassium (tegafur/gimeracil/oteracil potassium)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Cervical Cancer, Chemotherapy | Phase 1, Phase 2 | Status: UNKNOWN